Clinical Trial Update: Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing sacubitril/valsartan to enalapril examines effects on aortic stiffness in patients with heart failure with reduced ejection fra…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• Enalapril (enalapril)
• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Heart Failure and Reduced Ejection Fraction | Phase 4 | Status: COMPLETED | Results posted: 2020-03-19